Delivery Order SPE2DB22D9239-SPE2DB25FDL40
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $83,162.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This delivery order was issued without a set-aside designation on August 11, 2025, with an ultimate completion date of August 12, 2025. The award represents a discrete purchase order under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency (DLA) for the supply of Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by August 20, 2025, and represents performance at the contractor's Park Ridge facility. This delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 25, 2025, for Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, valued at approximately $33k, represents a single purchase action issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid...
- The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,434.34 by the Defense Logistics Agency on July 30, 2025, for the supply of Cabometyx 60 mg tablets (30-count units). The delivery order is issued without a set-aside designation and is scheduled for completion by July 31, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $30,818.04 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of CABOMETYX 40 mg tablet bottles, with a period of performance through April 11, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued at up to $4,999,999, which allows the agency to issue delivery orders for a broad range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,221.97, is for the supply of the drug Cabometyx 40mg tablets. It is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $45,519.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of CABOMETYX 60 MG TABLET 30S to support the recurring pharmaceutical needs of military health facilities. This order is part of a larger single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL40Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,265.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a direct pharmaceutical supply fulfillment under DLA's pharmaceutical distribution operations. DMS Pharmaceutical Group, registered in the System for Award Management (SAM.gov) since 2001, serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC framework enables the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products supporting medical supply needs of military health facilities worldwide. No set-aside designation was used for this particular award, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business in the federal procurement market. Cabometyx, a targeted cancer therapy, represents the specialized pharmaceutical products that fall within the company's established portfolio of oncology treatments and other advanced medications delivered to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.3k | 8/27/25 |